Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1966 2
1967 2
1968 3
1969 3
1970 3
1971 7
1972 4
1973 3
1974 10
1975 8
1976 11
1977 7
1978 11
1979 9
1980 10
1981 5
1982 5
1983 3
1984 2
1985 7
1986 10
1987 4
1988 5
1990 6
1991 10
1992 8
1993 10
1994 6
1995 13
1996 10
1997 14
1998 23
1999 23
2000 16
2001 15
2002 9
2003 9
2004 8
2005 8
2006 8
2007 5
2008 10
2009 7
2010 2
2011 6
2012 5
2013 3
2014 5
2015 5
2016 1
2017 4
2018 2
2019 3
2020 7
2021 6
Text availability
Article attribute
Article type
Publication date

Search Results

392 results
Results by year
Filters applied: . Clear all
Page 1
A Phase I Study of ADCT-402 (Loncastuximab Tesirine), a Novel Pyrrolobenzodiazepine-Based Antibody-Drug Conjugate, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma.
Kahl BS, Hamadani M, Radford J, Carlo-Stella C, Caimi P, Reid E, Feingold JM, Ardeshna KM, Solh M, Heffner LT, Ungar D, He S, Boni J, Havenith K, O'Connor OA. Kahl BS, et al. Among authors: feingold jm. Clin Cancer Res. 2019 Dec 1;25(23):6986-6994. doi: 10.1158/1078-0432.CCR-19-0711. Epub 2019 Nov 4. Clin Cancer Res. 2019. PMID: 31685491 Free article. Clinical Trial.
Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis.
Marrakchi S, Guigue P, Renshaw BR, Puel A, Pei XY, Fraitag S, Zribi J, Bal E, Cluzeau C, Chrabieh M, Towne JE, Douangpanya J, Pons C, Mansour S, Serre V, Makni H, Mahfoudh N, Fakhfakh F, Bodemer C, Feingold J, Hadj-Rabia S, Favre M, Genin E, Sahbatou M, Munnich A, Casanova JL, Sims JE, Turki H, Bachelez H, Smahi A. Marrakchi S, et al. Among authors: feingold j. N Engl J Med. 2011 Aug 18;365(7):620-8. doi: 10.1056/NEJMoa1013068. N Engl J Med. 2011. PMID: 21848462 Free article.
Loncastuximab tesirine, an anti-CD19 antibody-drug conjugate, in relapsed/refractory B-cell acute lymphoblastic leukemia.
Jain N, Stock W, Zeidan A, Atallah E, McCloskey J, Heffner L, Tomlinson B, Bhatnagar B, Feingold J, Ungar D, Chao G, Zhang X, Qin Y, Havenith K, Kantarjian H, Wieduwilt MJ. Jain N, et al. Among authors: feingold j. Blood Adv. 2020 Feb 11;4(3):449-457. doi: 10.1182/bloodadvances.2019000767. Blood Adv. 2020. PMID: 32012214 Free PMC article. Clinical Trial.
Camidanlumab tesirine, an antibody-drug conjugate, in relapsed/refractory CD25-positive acute myeloid leukemia or acute lymphoblastic leukemia: A phase I study.
Goldberg AD, Atallah E, Rizzieri D, Walter RB, Chung KY, Spira A, Stock W, Tallman MS, Cruz HG, Boni J, Havenith KEG, Chao G, Feingold JM, Wuerthner J, Solh M. Goldberg AD, et al. Among authors: feingold jm. Leuk Res. 2020 Aug;95:106385. doi: 10.1016/j.leukres.2020.106385. Epub 2020 Jun 7. Leuk Res. 2020. PMID: 32521310 Clinical Trial.
The presymptomatic phase of Huntington disease.
Durr A, Gargiulo M, Feingold J. Durr A, et al. Among authors: feingold j. Rev Neurol (Paris). 2012 Nov;168(11):806-8. doi: 10.1016/j.neurol.2012.07.003. Epub 2012 Aug 15. Rev Neurol (Paris). 2012. PMID: 22902173 Review.
[Hereditary predispositions to colorectal cancer].
Bonaïti-Pellié C, Eisinger F, Feingold J, Frébourg T, Grandjouan S, Lasset C, Laurent-Puig P, Lecuru F, Millat B, Sobol H, Thomas G, Olschwang S. Bonaïti-Pellié C, et al. Among authors: feingold j. Gastroenterol Clin Biol. 2005 Jun-Jul;29(6-7):701-10. doi: 10.1016/s0399-8320(05)82159-1. Gastroenterol Clin Biol. 2005. PMID: 16142005 Free article. Review. French. No abstract available.
392 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page